Mangoceuticals Inc. (MGRX): Price and Financial Metrics
MGRX Price/Volume Stats
Current price | $0.22 | 52-week high | $3.18 |
Prev. close | $0.22 | 52-week low | $0.14 |
Day low | $0.21 | Volume | 213,400 |
Day high | $0.22 | Avg. volume | 1,119,487 |
50-day MA | $0.26 | Dividend yield | N/A |
200-day MA | $0.77 | Market Cap | 3.78M |
MGRX Stock Price Chart Interactive Chart >
Latest MGRX News From Around the Web
Below are the latest news stories about MANGOCEUTICALS INC that investors may wish to consider to help them evaluate MGRX as an investment opportunity.
FSLR Stock Alert: First Solar Scores New ‘Buy’ RatingFirst Solar stock is rising on Friday as investors in FSLR react to a new "buy" rating and $211 price target from Jefferies. |
General Motors Layoffs: What to Know About the Latest GM Job CutsGeneral Motors layoffs have the automobile company planning to cut roughly 1,300 jobs following the start of the new year. |
Why Is Mangoceuticals (MGRX) Stock Down 33% Today?Mangoceuticals stock is falling on Friday after the company put into effect a public offering for shares of MGRX. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's time to dive into the biggest pre-market stock movers for Friday morning as we check out the winners and losers today! |
Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public OfferingDallas, Texas, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (Nasdaq: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product (“GROW”) and erectile dysfunction (“ED”) drug (“Mango”), today priced its previously announced underwritten public offering of 4,000,000 shares of its common stock, par value $0.0001 per shar |
MGRX Price Returns
1-mo | 2.04% |
3-mo | -20.55% |
6-mo | -74.13% |
1-year | -88.30% |
3-year | N/A |
5-year | N/A |
YTD | -20.55% |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...